Form 8-K - Current report:
SEC Accession No. 0001104659-20-053569
Filing Date
2020-04-29
Accepted
2020-04-29 17:23:22
Documents
3
Period of Report
2020-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2018049d1_8k.htm 8-K 31249
2 EXHIBIT 1.1 tm2018049d1_ex1-1.htm EX-1.1 302833
3 EXHIBIT 5.1 tm2018049d1_ex5-1.htm EX-5.1 54425
  Complete submission text file 0001104659-20-053569.txt   389806
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 20831805
SIC: 2834 Pharmaceutical Preparations